These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 17565627)

  • 21. Barrett's esophagus: results of a multicentric survey. G.O.S.P.E. (Gruppo Operativo per lo Studio delle Precancerosi Esofagee.
    Bonelli L
    Endoscopy; 1993 Nov; 25(9):652-4. PubMed ID: 8119225
    [No Abstract]   [Full Text] [Related]  

  • 22. Low-grade dysplasia in Barrett's esophagus.
    Odze RD; Goldblum JR
    Clin Gastroenterol Hepatol; 2006 Nov; 4(11):1419-20; author reply 1420. PubMed ID: 17110303
    [No Abstract]   [Full Text] [Related]  

  • 23. Aspirin is not chemoprotective for Barrett's adenocarcinoma of the oesophagus in multicentre cohort.
    Gatenby PA; Ramus JR; Caygill CP; Winslet MC; Watson A
    Eur J Cancer Prev; 2009 Sep; 18(5):381-4. PubMed ID: 19620873
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Short segment Barrett's esophagus: ignorance may be bliss.
    Richter JE
    Am J Gastroenterol; 2006 Jun; 101(6):1183-5. PubMed ID: 16771934
    [TBL] [Abstract][Full Text] [Related]  

  • 25. What's new in columnar lined esophagus (Barrett's metaplasia)?
    Tadiparthi R; Bansal A; Sharma P
    Curr Opin Gastroenterol; 2008 Jul; 24(4):516-20. PubMed ID: 18622169
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Barrett's esophagus and cytokine polymorphisms-confusion about the content in the abstract/results section compared to the table given in a recent manuscript.
    Leodolter A
    Am J Gastroenterol; 2005 Dec; 100(12):2814. PubMed ID: 16393242
    [No Abstract]   [Full Text] [Related]  

  • 27. Barrett's esophagus: a retrospective analysis of 13 years surveillance.
    Switzer-Taylor V; Schlup M; Lübcke R; Livingstone V; Schultz M
    J Gastroenterol Hepatol; 2008 Sep; 23(9):1362-7. PubMed ID: 18205769
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidemiologic studies and the development of Barrett's esophagus.
    Cameron AJ
    Endoscopy; 1993 Nov; 25(9):635-6. PubMed ID: 8119220
    [No Abstract]   [Full Text] [Related]  

  • 29. Should we worry about the length of Barrett's esophagus?
    Shaheen NJ
    Gastrointest Endosc; 2005 Nov; 62(5):682-5. PubMed ID: 16246679
    [No Abstract]   [Full Text] [Related]  

  • 30. Barrett's esophagus: so what!
    van Blankenstein M
    Dis Esophagus; 2002; 15(1):1-4. PubMed ID: 12060035
    [No Abstract]   [Full Text] [Related]  

  • 31. Chemoprevention of adenocarcinoma associated with Barrett's esophagus: potential options.
    Neumann H; Mönkemüller K; Vieth M; Malfertheiner P
    Dig Dis; 2009; 27(1):18-23. PubMed ID: 19439956
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The incidence of esophageal adenocarcinoma in Barrett's esophagus has been overestimated.
    Desai TK; Singh J; Samala N; Subbiah P
    Am J Gastroenterol; 2011 Jul; 106(7):1364-5; author reply 1365-6. PubMed ID: 21731021
    [No Abstract]   [Full Text] [Related]  

  • 33. Cyclooxygenase-2 inhibitor therapy for the prevention of esophageal adenocarcinoma in Barrett's esophagus.
    Gupta RA; DuBois RN
    J Natl Cancer Inst; 2002 Mar; 94(6):406-7. PubMed ID: 11904306
    [No Abstract]   [Full Text] [Related]  

  • 34. Barrett's esophagus: A comprehensive review for the internist.
    Klavan H; Russell MB; Macklin J; Lee E; Aslanian HR; Muniraj T
    Dis Mon; 2018 Nov; 64(11):471-487. PubMed ID: 29880269
    [No Abstract]   [Full Text] [Related]  

  • 35. Helicobacter pylori infection and the risk of adenocarcinoma of the esophagus.
    Celiński K; Słomka M; Kasztelan-Szczerbińska B; Madro A; Cichoz-Lach H; Kurzeja A
    Ann Univ Mariae Curie Sklodowska Med; 2004; 59(1):424-7. PubMed ID: 16146024
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IL-1 RN polymorphism is not associated with Barrett's esophagus and esophageal adenocarcinoma.
    Moons LM; Siersema PD; Kuipers EJ; van Vliet AH; Kusters JG
    Am J Gastroenterol; 2005 Dec; 100(12):2818. PubMed ID: 16393246
    [No Abstract]   [Full Text] [Related]  

  • 37. Once or twice daily doses of proton pump inhibitor in treating Barrett's esophagus?
    Savarino V; Mela GS; Zentilin P; Celle G; Vigneri S
    Am J Gastroenterol; 1995 May; 90(5):845-6. PubMed ID: 7733108
    [No Abstract]   [Full Text] [Related]  

  • 38. The association between alcohol and reflux esophagitis, Barrett's esophagus, and esophageal adenocarcinoma.
    Anderson LA; Cantwell MM; Watson RG; Johnston BT; Murphy SJ; Ferguson HR; McGuigan J; Comber H; Reynolds JV; Murray LJ
    Gastroenterology; 2009 Mar; 136(3):799-805. PubMed ID: 19162028
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The evidence base of proton pump inhibitor chemopreventative agents in Barrett's esophagus--the good, the bad, and the flawed!
    Leedham S; Jankowski J
    Am J Gastroenterol; 2007 Jan; 102(1):21-3. PubMed ID: 17266685
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-reflux surgery is superior to medical management in patients with Barrett's esophagus with low-grade dysplasia.
    Chandrasoma P
    Am J Gastroenterol; 2007 Sep; 102(9):2111-2. PubMed ID: 17727447
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.